Mov Disord Vol 33, Suppl 2 Archives - Page 105 of 177 - MDS Abstracts

2018 International Congress
Receptivity to deep brain stimulation surgery among patients with essential tremor
A. Patel, C. Chow, V. Kakade, K. Nalamada, K. Para, S. Schaefer, D. Shah, E. Louis (New Haven, CT, USA)
Objective: To identify essential tremor (ET) patients’ attitudes towards deep brain stimulation (DBS) surgery, and how a patient’s level of impairment, assessment of risk, and…
2018 International Congress
Early Experiences with Entrainment by Transcranial Alternating Current Stimulation in Patients with Essential Tremor
F. Maguire, T. Munteanu, A. Khatoun, M. Mc Laughlin, T. Lynch, R. Reilly (Dublin, Ireland)
Objective: To explore the effect of transcranial electrical stimulation applied to the head in modulating tremor phase in controls and in patients diagnosed with Essential…
2018 International Congress
Cognitive functions are associated with tremor severity in essential tremor
C.Y. Wei, W.K. Tsai, H.C. Lai, W.C. Chang, T. Taira (Changhua Country, Taiwan)
Objective: To study the relationship between cognitive function and tremor severity in essential tremor Background: Essential tremor (ET) is a common neurological disorder, which characterized…
2018 International Congress
Parkinson’s disease against the background of an essential tremor in people of Uzbek nationality
R. Matmurodov, K. Khalimova, F. Odinayev (Tashkent, Uzbekistan)
Objective: To study clinical manifestations of Parkinson's disease (PD) on the background of essential tremor (ET) in persons of Uzbek nationality. Background: Parkinson's disease often…
2018 International Congress
Rivastigmine solution in the one-year treatment of Parkinson’s disease dementia and dementia with Lewy bodies
P.Y. Chiu (Changhua, Taiwan)
Objective: Efficacy and safety of rivastigmine solution in the treatment of dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) is not well studied…
2018 International Congress
An analysis of cortical thickness in early Parkinson’s disease patients with cognitive impairment
M. Mei, K. Nie, Y. Gao, Y. Zhang, L. Wang (Guangzhou, China)
Objective: To explore a possible relation between the changes of cortical thickness and cognitive deficits in patients with Parkinson’s disease (PD). Background: Cognitive impariment usually…
2018 International Congress
An investigation of the relationship between computational neuropsychological testing outcomes and symptoms of Parkinson’s disease
L. Jiang, Y. Zhu, Z. Ye, Z. Pei, L. Chen (Guangzhou, China)
Objective: The aim of this study was to investigate the relationship between cognition and other symptoms of Parkinson’s disease (PD) using computational neuropsychological tests. Background:…
2018 International Congress
Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease
T. Tropea, K. Maddy, J. Rick, J. Trojanowkski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)
Objective: To evaluate the effect of genetic variants implicated in Alzheimer’s disease (AD) risk on cognitive decline in Parkinson’s disease (PD). Background: People with PD…
2018 International Congress
Novel GBA risk factor gene mutation p.W378R in a kindred with Gaucher’s disease and Parkinson’s disease
M. Lubomski, M. Hayes, M. Kennerson, M. Ellis, S. Chu, J. Blackie, J. O’Sullivan, G. Nicholson (Sydney, Australia)
Objective: We undertook mutation analysis of the Glucocerebrosidase gene (GBA) gene in a large three-generational Australian kindred consisting of some individuals with both type 1…
2018 International Congress
The Polymorphism of SREBF1 Gene rs11868035 G/A Is Associated with susceptibility to Parkinson’s disease in a Chinese Population
F. Lou, M. Li, XG. Luo, Y. Ren (Shenyang, China)
Objective: The potential association between the single-nucleotide polymorphism of two functional genes (SREBF1gene rs11868035 and USP25 gene rs2823357) and susceptibility to Parkinson’s disease (PD) in…